Organigram Global (OGI) Change in Accured Expenses (2018 - 2026)

Organigram Global (OGI) posted quarterly Change in Accured Expenses of -$13.6 million for Q1 2026, down 469.07% year-on-year from $3.7 million in Q1 2025, and up 17.26% on a QoQ basis from -$16.4 million in Q4 2025.

Organigram Global (OGI) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Change in Accured Expenses for 7 consecutive years, with -$13.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Accured Expenses fell 469.07% year-over-year to -$13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.7 million (down 1585.25% YoY) and the FY2021 annual result came in at $170000.0, changed N/A from the prior year.
  • Change in Accured Expenses advanced to -$13.6 million in Q1 2026 per OGI's latest filing, from -$16.4 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for OGI reached as high as -$2.4 million in Q1 2025 and fell as low as -$16.4 million in Q4 2025.
  • A 3-year average of -$10.2 million and a median of -$10.9 million in 2026 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2025 — Change in Accured Expenses plunged 98.59% — and 2026, when it plunged 469.07%.
  • Year by year, Change in Accured Expenses stood at -$8.3 million in 2024, then tumbled by 98.59% to -$16.4 million in 2025, then advanced by 17.26% to -$13.6 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$13.6 million, -$16.4 million, and -$2.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Organigram Global 121.15 Mn 154.23 Mn 28.97 Mn -13.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.60 Mn
Mar 31, 2026 -13.60 Mn
Dec 31, 2025 -16.43 Mn
Dec 31, 2025 -16.43 Mn
Mar 31, 2025 -2.39 Mn
Mar 31, 2025 -2.39 Mn
Dec 31, 2024 -8.27 Mn
Dec 31, 2024 -8.27 Mn
May 31, 2021 4.38 Mn
May 31, 2021 4.38 Mn
Feb 28, 2021 3.87 Mn
Feb 28, 2021 3.87 Mn
Nov 30, 2020 -322,000.00
Nov 30, 2020 -322,000.00
May 31, 2020 10.89 Bn
May 31, 2020 10.89 Bn
Feb 29, 2020 15,458.00
Feb 29, 2020 15,458.00
May 31, 2019 6.27 Mn
May 31, 2019 6.27 Mn